Clinical trials: Simvastatin

Alzheimer's Disease

GSK2647544 RD, DDI in Healthy Young and Elderly Volunteers

• Terminated
• Age: 18 years and older
• Phase 1

GSK2647544 is an orally available, selective inhibitor of Lp PLA2 that is being developed for the treatment of Alzheimer's disease.

Trial name

NCT01978327

Testing

GSK2647544, drug-drug interaction

Where

United Kingdom

Volunteers

12 people, healthy volunteers welcome

Sponsor

GlaxoSmithKline